Literature DB >> 9147082

Effects of radiation on the normal prostate gland.

M T Sheaff1, S I Baithun.   

Abstract

Prostate cancer is one of the commonest tumours of adult males. It shows a range of biological behaviour: many tumours are discovered incidentally; others will kill by producing widespread metastatic disease. Despite the fact that radiation is frequently used in the treatment of a range of pelvic lesions, including adenocarcinoma of the prostate itself, studies on the morphological changes in the normal prostate gland after irradiation are limited. This seems particularly surprising following the increasing use of needle biopsy specimens to assess the prostate. Patients who receive pelvic irradiation often suffer from lower urinary tract symptoms such as frequency and dysuria and it is possible that these may be related to prostatic and/or periprostatic injury. We therefore investigated the prostate glands removed at cystoprostatectomy for transitional cell carcinomas of the bladder which had received radiotherapy pre-operatively. The changes were compared to control prostatic tissue from transurethral resection specimens for benign myoadenomatous hyperplasia. We found a range of inflammatory, fibrotic and reactive cytological features, including many of the changes seen in benign hyperplasia, but these were significantly more exaggerated in the post-radiation group. In addition intraprostatic vascular and neural changes were prominent. This study documents radiation-induced changes throughout the normal prostate gland and neighbouring soft tissue and has particular importance in current pathological practice with the increasing and widespread use of needle biopsies in the diagnosis and follow-up of prostate cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9147082     DOI: 10.1046/j.1365-2559.1997.d01-621.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

2.  Comparing the toxicity and disease control rate of radiotherapy for prostate cancer between salvage settings after high-intensity focused ultrasound therapy and initial settings.

Authors:  Toshihisa Kuroki; Sunao Shoji; Toyoaki Uchida; Takeshi Akiba; Shigeto Kabuki; Ryuta Nagao; Tsuyoshi Fukuzawa; Yoshitsugu Matsumoto; Tomomi Katsumata; Natsumi Futakami; Tatsuya Mikami; Yoji Nakano; Yuri Toyoda; Tsuyoshi Takazawa; Etsuo Kunieda; Akitomo Sugawara
Journal:  J Radiat Res       Date:  2022-07-19       Impact factor: 2.438

3.  Relationship between prostate volume changes and treatment duration of neoadjuvant androgen deprivation during intensity-modulated radiation therapy for Japanese patients with prostate cancer.

Authors:  Masashi Tomida; Kuniyasu Okudaira; Takeshi Kamomae; Hiroshi Oguchi; Yoshikazu Miyake; Kazuo Yoneda; Yoshiyuki Itoh
Journal:  Nagoya J Med Sci       Date:  2016-08       Impact factor: 1.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.